Skip to content

RNA Pioneering

Active
Public limited companyfounded 1995active for 30 yearsRijvisschestraat 120, 9052 Gent, BelgiumKBO/BCE: BE 0456.792.695
Summary

RNA Pioneering has been active since 1995 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5.5m and a net result of -€128,247. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 94% of 3,863 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
RNA PioneeringActiveChecked score 94/100
Risk analysis ReportCompare

Overview

Official details

Source: KBO
Status
Active since 29-12-1995 Normal situation
Activity
Business and other management consultancy NACE 70200and 2 others
Joint committee
207 Paritair Comité voor de bedienden uit de scheikundige nijverheid · annual accounts 2021
Establishment unit
2.074.634.416 9052 Gent, since 18-02-1999
Financial year end
31 December
Peppol
Reachable since 24-11-2023
Company details

Board and ownership

Board
  • BELLEVUEManaging director · permanent representative Christiaan Cardon
Shareholders
  • BELLEVUE30-06-2025 annual accounts of BELLEVUE
  • BELINVEST2024 annual accounts of BELINVEST
  • MASC-INVEST29-10-2025 annual accounts of MASC-INVEST
and 1 other shareholder
Holdings
Shares in 1 company Ziphius
Board & ownership

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
-€111,461
▼ 37.3%
Loss
€128,247
▲ 1.8%
Equity
€5.5m
▼ 2.3%
Total assets
€5.6m
▼ 0.8%
Financials
Score breakdownraises riskLiquidity: current ratio 1.94, cash €198,540Loss of €128,247, the second in a row (financial year 2025)lowers riskSize: total assets €5.6mFounded in 1995Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 50% of small companies in wholesale trade (NACE 46)
Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Average
Solvency 100=
equity 97.9% of total assets
Liquidity 54+3
short-term debt 2.1% · cash 3.5%
Profitability 16=
return on assets -2.3%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (4,372 companies, NACE 46, small)
Last 24 months 12-2024: 0.5% 01-2025: 0.5%● unchanged vs 12-2024 02-2025: 0.5%● unchanged vs 01-2025 03-2025: 0.5%● unchanged vs 02-2025 04-2025: 0.5%● unchanged vs 03-2025 05-2025: 0.6%▲ +0.1 percentage points vs 04-2025 06-2025: 0.6%● unchanged vs 05-2025 07-2025: 0.7%▲ +0.1 percentage points vs 06-2025 08-2025: 0.8%▲ +0.1 percentage points vs 07-2025highest value 09-2025: 0.3%▼ -0.5 percentage points vs 08-2025 10-2025: 0.3%● unchanged vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.4%▲ +0.1 percentage points vs 04-2026 06-2026: 0.3%▼ -0.1 percentage points vs 05-2026 07-2026: 0.4%▲ +0.1 percentage points vs 06-2026 08-2026: 0.1%▼ -0.3 percentage points vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026 11-2026: < 0.1%▼ -0.1 percentage points vs 10-2026lowest value
Credit of up to €500,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.94 (9.48 in 2024), above the usual 1.5. Short-term debt is 2.1% and cash 3.5% of total assets. 2.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, small). It does better than 92% of them on solvency, 72% on liquidity, 10% on profitability and 26% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €5.6m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Founded in 1995
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Liquidity: current ratio 1.94, cash €198,540
NBB · annual accounts
raises risk · Loss of €128,247, the second in a row (financial year 2025)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-07-2026, 15 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
15 days early
2024
27 days late
2023
30 days late
2022
59 days late
2021
40 days late
2020
122 days late
2019
122 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 55 days after the deadline. In the sector (NACE 70), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 August (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Risk: 3 loss-making years in a rowloss in financial year 2025 -€128,247 View
  • Caution: Lower net result than 89% of companies in head offices and management consultancysector median €54,042 · 3,862 companies -€128,247 View

Recent changes

  1. · Gazette deed Capital increase of €1,020,276.64 to €8,730,656.64
  2. · Gazette deed Registered office moved from Oostkamp to ZwijnaardePermanent representative: Christiaan Cardon
  3. · Gazette deed Capital & shares
All 22 events

Companies linked to RNA Pioneering

Comparable companies

These companies have the same main activity as RNA Pioneering: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €5.1m and €6.6m, founded between 1991 and 1999.

CompanyTotal assetsGross margin
RNA Pioneering Gent€5.6m-€0.1m
VANKA INVEST Wortegem-Petegem€5.6m-€0.1m
LMCL Wichelen€5.1m-€0.002m
V.M.A. GROUP Nazareth-De Pinte€6.6m-€0.02m
PLUS MINUS Antwerpen€5.7m-€0.05m
ADUFIN Havelange€6.1m-€0.06m
V.D.S. Staden€5.7m-€0.03m
Full comparison

Key facts about RNA Pioneering
What is the company number of RNA Pioneering?
The company number of RNA Pioneering is 0456.792.695. The VAT number is the same number with BE in front: BE 0456.792.695.
Where is RNA Pioneering based?
The registered office is at Rijvisschestraat 120, 9052 Gent.Company details
What does RNA Pioneering do?
According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
What is the legal form of RNA Pioneering?
The legal form of RNA Pioneering is Public limited company (NV).
When was RNA Pioneering founded?
RNA Pioneering was founded on 29-12-1995.
Is RNA Pioneering still active?
Yes, RNA Pioneering is an active enterprise in the KBO register.
How many employees does RNA Pioneering have?
RNA Pioneering had an average of 0.9 full-time equivalents in financial year 2021, according to the filed annual accounts.Financials
Which joint committee does RNA Pioneering fall under?
In its 2021 annual accounts, RNA Pioneering states joint committee 207 (Paritair Comité voor de bedienden uit de scheikundige nijverheid).
What is the turnover of RNA Pioneering?
The annual accounts for financial year 2025 state no turnover. In financial year 2021 turnover was €41,970.
Is RNA Pioneering profitable?
In financial year 2025, RNA Pioneering made a loss of €128,247.
Where can I find the annual accounts of RNA Pioneering?
RNA Pioneering filed 30 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of RNA Pioneering due?
RNA Pioneering must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure